ClinicalTrials.Veeva

Menu

Neoadjuvant Database (NEOADJ)

C

Centre Georges Francois Leclerc

Status

Enrolling

Conditions

Neoadjuvant Treatment in Breast Cancer

Treatments

Drug: Neoadjuvant therapy

Study type

Observational

Funder types

Other

Identifiers

NCT04031612
AB2009SEIN

Details and patient eligibility

About

The NEOADJ Database base contains data collected during the regular clinical patient management (sociodemographic, clinical, pathological, radiological, biological, disease evolution...). This database allows easy access to information in a centralized and structured way.

This cohort is used to gather insights for research purposes. All data collected come from medical files of patients managed at Centre Georges Francois Leclerc, Dijon, France.

Enrollment

2,000 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women followed for breast cancer in Georges Francois Leclerc Center
  • Neoadjuvant chemotherapy
  • Age >= 18

Exclusion criteria

  • Males
  • Metastatic breast cancer

Trial design

2,000 participants in 1 patient group

Neoadjuvant Breast Cancer
Description:
Patients undergoing neoadjuvant therapy for breast cancer
Treatment:
Drug: Neoadjuvant therapy

Trial contacts and locations

1

Loading...

Central trial contact

AURELIE BERTAUT, MD, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems